Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Visible Light Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118125897A reveals a room-temperature visible-light method for Z-selective monofluoroolefin synthesis, offering significant cost and supply chain advantages for pharmaceutical manufacturing.
Patent CN108623494B details a green photocatalytic method for synthesizing imines using sulfur-containing aza metalloporphyrin, offering high selectivity and cost reduction.
Patent CN105985290B reveals oxidant-free visible light photocatalysis for isoquinoline derivatives. This method ensures high purity and supply chain stability for pharmaceutical intermediates manufacturing.
Patent CN113121338A reveals a green photocatalytic method for alpha-hydroxylation using air and visible light, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN111961011B reveals a metal-free visible light method for benzothiazole derivatives, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN112358389B reveals a green LED-driven route for 2-MNQ. Eliminate chromium waste and reduce costs in vitamin K3 manufacturing with our scalable photochemical technology.
Patent CN118388585A enables high-yield amide synthesis with low racemization. Offers supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN118388585A reveals green visible light catalysis for amide synthesis. Reduces racemization and enhances supply chain reliability for pharmaceutical intermediates globally.
Patent CN112358389A details a green LED-driven synthesis of Vitamin K3 intermediate, offering metal-free production and superior purity for reliable supply chains.
Novel ruthenium-catalyzed visible light method for gamma-hydroxy ketones offers mild conditions and high atom economy for pharma intermediates.
Novel ruthenium-catalyzed visible light method for gamma-hydroxy ketones offers mild conditions and high atom economy for pharma intermediates.
Patent CN106977488B reveals visible light promoted synthesis. Offers mild conditions and high purity for pharmaceutical intermediate manufacturing supply chains.
Patent CN112480020A details a green visible light method for synthesizing benzoxazoles. This report analyzes cost reduction and supply chain reliability for pharma intermediates.
Patent CN113717071B details a metal-free visible light catalytic method for acetamide compounds, offering cost reduction and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN108586283A enables visible-light synthesis of alpha-azide ketones using air oxidant. Reduces metal waste and offers cost-effective pharmaceutical intermediate manufacturing solutions.
Novel visible-light method for isoquinoline derivatives offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Patent CN113480468B enables green visible light catalysis for isoindigo. Offers mild conditions and simplified purification for supply chain efficiency.
Patent CN109705006B reveals a green, visible-light method for diaryl sulfides. Eliminate metal residues and reduce costs in pharmaceutical intermediate manufacturing.
Patent CN109705006B details a green, visible-light method for diaryl sulfides, offering cost reduction and metal-free purity for pharmaceutical intermediates manufacturing.
Patent CN116178243A reveals a mild visible-light photocatalytic method for carbazole synthesis, offering significant cost reduction and high purity for pharmaceutical intermediates manufacturing.